Predictive biomarkers for treatment selection: statistical considerations

A New Initiative on Precision Medicine

(2015) Francis S. Collins et al.   NEW ENGLAND JOURNAL OF MEDICINE

The current status of biomarkers for predicting toxicity

(2013) Sarah Campion et al.   Expert Opinion on Drug Metabolism & Toxicology

Statistical and Practical Considerations for Clinical Evaluation of Predictive Biomarkers

(2013) M.-Y. C. Polley et al.   JNCI-Journal of the National Cancer Institute

The Cancer Genome Atlas Pan-Cancer analysis project

(2013) John N Weinstein et al.   NATURE GENETICS

Bayesian methods for design and analysis of safety trials

(2013) Karen L. Price et al.   PHARMACEUTICAL STATISTICS

Guidance on the implementation and reporting of a drug safety Bayesian network meta-analysis

(2013) David Ohlssen et al.   PHARMACEUTICAL STATISTICS

Epidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC)

(2013) Kunihiko Kobayashi et al.   Targeted Oncology

Safety Biomarkers in Preclinical Development

(2013) V. G. Sasseville et al.   VETERINARY PATHOLOGY

A Mixture Model to Correct Misclassification of Gestational Age

(2012) Marcelo L. Urquia et al.   ANNALS OF EPIDEMIOLOGY

Assessment of performance of survival prediction models for cancer prognosis

(2012) Hung-Chia Chen et al.   BMC Medical Research Methodology

Developing and Validating Continuous Genomic Signatures in Randomized Clinical Trials for Predictive Medicine

(2012) S. Matsui et al.   CLINICAL CANCER RESEARCH

NGS catalog: A database of next generation sequencing studies in humans

(2012) Junfeng Xia et al.   HUMAN MUTATION

Cancer biomarkers: selecting the right drug for the right patient

(2012) Gary J. Kelloff et al.   NATURE REVIEWS DRUG DISCOVERY

Adaptive Clinical Trial Designs for Simultaneous Testing of Matched Diagnostics and Therapeutics

(2011) H. I. Scher et al.   CLINICAL CANCER RESEARCH

Integrating biomarkers in clinical trials

(2011) Marc Buyse et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Biomarkers in chronic kidney disease: a review

(2011) Robert G. Fassett et al.   KIDNEY INTERNATIONAL

Integrating predictive biomarkers and classifiers into oncology clinical development programmes

(2011) Robert A. Beckman et al.   NATURE REVIEWS DRUG DISCOVERY

A statistician's perspective on biomarkers in drug development

(2011) Martin Jenkins et al.   PHARMACEUTICAL STATISTICS

Model-based clustering of microarray expression data via latent Gaussian mixture models

(2010) P. D. McNicholas et al.   BIOINFORMATICS

The Cross-Validated Adaptive Signature Design

(2010) B. Freidlin et al.   CLINICAL CANCER RESEARCH

Clinical trials for predictive medicine: new challenges and paradigms

(2010) Richard Simon   Clinical Trials

Adaptive patient enrichment designs in therapeutic trials

(2009) Sue-Jane Wang et al.   BIOMETRICAL JOURNAL

Development of biomarker classifiers from high-dimensional data

(2009) Songjoon Baek et al.   BRIEFINGS IN BIOINFORMATICS

A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker Codevelopment

(2009) S. E. Taube et al.   JNCI-Journal of the National Cancer Institute

Integration and use of biomarkers in drug development, regulation and clinical practice: a US regulatory perspective

(2008) Shashi Amur et al.   Biomarkers in Medicine

Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer

(2008) Rafael G. Amado et al.   JOURNAL OF CLINICAL ONCOLOGY

Enabling personalized cancer medicine through analysis of gene-expression patterns

(2008) Laura J. van 't Veer et al.   NATURE

A graphical approach to sequentially rejective multiple test procedures

(2008) Frank Bretz et al.   STATISTICS IN MEDICINE